Onco-peptide loaded autologous dendritic cells

TERMINATED · PHASE1, PHASE2 · Metastatic Breast Cancer

all patients recruited

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.